Anti-competitive behaviour as a ground for compulsory licensing of pharmaceutical patents in South Africa
Date
2023-09-14
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
University of the Witwatersrand, Johannesburg
Abstract
While the South African Patents Act provides for compulsory licensing in instances of an abuse of patent rights, millions of South Africans remain unable to access essential medicines because of inter alia the high prices charged by pharmaceutical patent holders. This research explores the idea of utilising Article 31(k) of the TRIPS agreement – which allows for compulsory licences to be issued to remedy anti-competitive behaviour – to ensure access to patented essential medicines. The central argument in the report is that compulsory licenses on Article 31(k) grounds should be granted by the competition authorities after having found anti-
competitive behaviour on the part of the pharmaceutical patent holder. Moreover, this research provides solutions and recommendations to appropriately deal with the role of the competition authorities in the regulation of patented pharmaceutical
Description
A research report submitted in partial fulfilment of the requirements for the degree of Master of Laws by Coursework and Research Report , 2023at the University of the Witwatersrand, Johannesburg, 2023
Keywords
South African Patents Act, Pharmaceutical, Pharmaceutical patent, Pharmaceutical licensing, UCTD
Citation
Omar, Fathima. (2023). Anti-competitive behaviour as a ground for compulsory licensing of pharmaceutical patents in South Africa [Master’s dissertation University of the Witwatersrand, Johannesburg]. WireDSpace. https://hdl.handle.net/10539/38676